EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Survival trends in chemorefractory unresectable intrahepatic cholangiocarcinoma and the effect of resin-based Yttrium-90 radioembolization: surveillance, epidemiology and end results database vs. tertiary cancer center



Survival trends in chemorefractory unresectable intrahepatic cholangiocarcinoma and the effect of resin-based Yttrium-90 radioembolization: surveillance, epidemiology and end results database vs. tertiary cancer center



Journal of Vascular and Interventional Radiology 25(3): S103-S104




(PDF emailed within 0-6 h: $19.90)

Accession: 064580023

Download citation: RISBibTeXText

DOI: 10.1016/j.jvir.2013.12.291



Related references

Yttrium-9 Radioembolization for Unresectable Standard-chemorefractory Intrahepatic Cholangiocarcinoma Survival, Efficacy, and Safety Study. 2012

Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study. Cardiovascular and Interventional Radiology 36(2): 440-448, 2013

Survival trends in unresectable hepatocellular carcinoma and the effect of DEB-TACE: surveillance, epidemiology and end results database vs. tertiary cancer center. Journal of Vascular and Interventional Radiology 25(3): S25-S26, 2014

Prognostic Factors in Overall Survival of Patients with Unresectable Intrahepatic Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in Therapy-Nave Patients. Cardiovascular and Interventional Radiology, 2018

Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival. Cardiovascular and Interventional Radiology 35(1): 105-116, 2012

Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results. Journal of Cancer Research and Clinical Oncology (): -, 2016

PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma. Clinical Nuclear Medicine 39(11): 944-950, 2015

Standardized Added Metabolic Activity Predicts Survival After Intra-arterial Resin-Based 90Y Radioembolization Therapy in Unresectable Chemorefractory Metastatic Colorectal Cancer to the Liver. Clinical Nuclear Medicine 41(2): E76-E81, 2016

Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patients. Annals of Surgical Oncology 22(3): 794-802, 2015

Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma. Future Oncology 13(15): 1301-1310, 2017

Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis. European Journal of Surgical Oncology 41(1): 120-127, 2015

A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases. Journal of Cancer Research and Clinical Oncology 140(4): 537-547, 2014

(P050) Yttrium-90 Radioembolization for Unresectable, Chemorefractory Colorectal Cancer Liver Metastases in KRAS Wild-type and Mutant Patients. Oncology 29(4 Suppl 1): -, 2015

Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization. Journal of Vascular and Interventional Radiology 25(2): 256-265, 2014

Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. Journal of Vascular and Interventional Radiology 24(8): 1227-1234, 2014